Adare Pharmaceuticals

Articles

This whitepaper describes the microencapsulation process of coacervation using both aqueous and solvent pathways, and the many benefits for drug developers.

Expanding Solutions for Challenging APIs Through Coacervation V2

Expanding Solutions for Challenging APIs Through Coacervation

http://www.pharmtech.com/pt_w/patientadherence


	This session of PharmaTalks focuses on the challenges of medication adherence in children and patients with swallowing disorders (dysphasia). The session will discuss the industry trends associated with these challenges, the mechanism of swallowing, as well as the current solutions and associated gaps addressing these challenges.  The final part of the session will discuss a novel, patient-centric oral solution, leveraging unique taste-masking capabilities combined with the Parvulet

 enables a solid powder or tablet to convert to a semi-solid in the presence of water within 30 seconds. The final dosage is easily administered as a soft food-like texture ideal for pediatric and geriatric populations (including those with dysphagia).

		Understand the current challenges with pediatric and dysphagic patients associated with medication compliance

		Explore the details and mechanisms associated with swallowing 

		Learn about the gaps with current oral solutions for pediatrics and dysphagic patients and how taste masking, combined with the Parvulet technology, provides a novel patient-centric solution.

 Dr. Luigi Boltri, Director, Technology Development, Adare Pharmaceuticals

Webcasts

This session of PharmaTalks focuses on the challenges of medication adherence in children and patients with swallowing disorders (dysphasia).

On demand presentation

Register free

Advancing Medication Adherence and Accurate Dosing with Pediatrics and Patients with Dysphagia

A Patient-Centric Solution

What you will learn: 
* Dosage form innovations can increase patient adherence. 
* Parvulet offers a solution for patients with swallowing difficulties.